Interestingly, although MYC amplification frequently occurs in advanced stages of ESCC, the analysis we did to validate the prognostic value of MYC using the TCGA ESCA database showed that MYC expression did not correlate with patient survival (Fig. 3D). The gene discussed is MYC; the disease is esophageal squamous cell carcinoma.